RecruitingNCT04229966

Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases

A Real World, Multicenter, Prospective, Observational Study to Compare Effectiveness of Surgical Treatments in Patients With Acute Epidural Hematoma


Sponsor

RenJi Hospital

Enrollment

2,000 participants

Start Date

Nov 2, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multicenter, prospective, and observational real-world study aimed at investigating the current situation of surgical treatments and prognosis for acute epidural hematoma in China, and analyzing the optimization of therapy.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

  • Clear medical history of traumatic brain injury;
  • within 12 hours after injury;
  • Supratentorial unilateral acute epidural hematoma on first head CT scan examination;
  • The admitting neurosurgeon considers that the epidural hematoma needs to be evacuated with surgical treatment;
  • With informed consent to surgery and trial participation.

Exclusion Criteria6

  • Previous intracranial surgery prior to trauma;
  • Patients with a score of 3 on the GCS, with bilateral fixed and dilated pupils, bleeding diathesis or defective coagulation, or an injury that was deemed to be unsurvivable;
  • CT demonstrates associated other intracranial hematomas e.g. subdural, intracerebral hemorrhage, or large size infarction, which are the main causes of operation;
  • Patients who had injury of the oculomotor nerve;
  • Severe pre-existing disability or severe co-morbidity which would lead to a poor outcome even if the patient is supposed to a good recovery from the TBI;
  • Pregnant female.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04229966


Related Trials